vs
GOLD RESOURCE CORP（GORO）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
GOLD RESOURCE CORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.4倍（$51.3M vs $35.5M），GOLD RESOURCE CORP净利率更高（35.1% vs -304.2%，领先339.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 295.5%），GOLD RESOURCE CORP自由现金流更多（$15.3M vs $-47.3M），过去两年GOLD RESOURCE CORP的营收复合增速更高（65.6% vs 60.5%）
黄金资源公司是一家总部位于加拿大温哥华的矿业企业，目前专注于开发位于美国犹他州与内华达州交界处的金泉金银矿。公司成立于2006年，目前分别在加拿大多伦多证券交易所和美国OTCQX市场挂牌上市，核心业务聚焦贵金属矿的勘探与开发。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
GORO vs RXRX — 直观对比
营收规模更大
GORO
是对方的1.4倍
$35.5M
营收增速更快
RXRX
高出386.2%
295.5%
净利率更高
GORO
高出339.3%
-304.2%
自由现金流更多
GORO
多$62.6M
$-47.3M
两年增速更快
GORO
近两年复合增速
60.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $51.3M | $35.5M |
| 净利润 | $18.0M | $-108.1M |
| 毛利率 | 51.5% | 59.8% |
| 营业利润率 | 38.9% | -304.8% |
| 净利率 | 35.1% | -304.2% |
| 营收同比 | 295.5% | 681.7% |
| 净利润同比 | 261.6% | 39.6% |
| 每股收益（稀释后） | $0.14 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GORORXRX
| Q4 25 | $51.3M | $35.5M | ||
| Q3 25 | $24.9M | $5.2M | ||
| Q2 25 | $11.2M | $19.2M | ||
| Q1 25 | $12.4M | $14.7M | ||
| Q4 24 | $13.0M | $4.5M | ||
| Q3 24 | $13.3M | $26.1M | ||
| Q2 24 | $20.8M | $14.4M | ||
| Q1 24 | $18.7M | $13.8M |
净利润GORORXRX
| Q4 25 | $18.0M | $-108.1M | ||
| Q3 25 | $-4.7M | $-162.3M | ||
| Q2 25 | $-11.5M | $-171.9M | ||
| Q1 25 | $-8.3M | $-202.5M | ||
| Q4 24 | $-11.1M | $-178.9M | ||
| Q3 24 | $-12.7M | $-95.8M | ||
| Q2 24 | $-27.0M | $-97.5M | ||
| Q1 24 | $-5.7M | $-91.4M |
毛利率GORORXRX
| Q4 25 | 51.5% | 59.8% | ||
| Q3 25 | 25.0% | -183.8% | ||
| Q2 25 | -39.4% | -4.9% | ||
| Q1 25 | -11.8% | -48.0% | ||
| Q4 24 | -46.7% | -181.4% | ||
| Q3 24 | -65.3% | 53.7% | ||
| Q2 24 | -17.3% | 36.2% | ||
| Q1 24 | -11.6% | 19.1% |
营业利润率GORORXRX
| Q4 25 | 38.9% | -304.8% | ||
| Q3 25 | -14.9% | -3327.6% | ||
| Q2 25 | -102.4% | -916.8% | ||
| Q1 25 | -63.1% | -1297.9% | ||
| Q4 24 | -96.9% | -4042.4% | ||
| Q3 24 | -122.7% | -377.1% | ||
| Q2 24 | -52.1% | -697.4% | ||
| Q1 24 | -40.4% | -698.4% |
净利率GORORXRX
| Q4 25 | 35.1% | -304.2% | ||
| Q3 25 | -18.7% | -3135.3% | ||
| Q2 25 | -102.3% | -894.2% | ||
| Q1 25 | -67.3% | -1373.3% | ||
| Q4 24 | -85.9% | -3935.5% | ||
| Q3 24 | -95.5% | -367.5% | ||
| Q2 24 | -129.9% | -676.6% | ||
| Q1 24 | -30.4% | -662.4% |
每股收益（稀释后）GORORXRX
| Q4 25 | $0.14 | $-0.17 | ||
| Q3 25 | $-0.03 | $-0.36 | ||
| Q2 25 | $-0.09 | $-0.41 | ||
| Q1 25 | $-0.07 | $-0.50 | ||
| Q4 24 | $-0.11 | $-0.56 | ||
| Q3 24 | $-0.14 | $-0.34 | ||
| Q2 24 | $-0.30 | $-0.40 | ||
| Q1 24 | $-0.06 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $44.0M | $1.1B |
| 总资产 | $184.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资GORORXRX
| Q4 25 | $25.0M | $743.3M | ||
| Q3 25 | $9.8M | $659.8M | ||
| Q2 25 | $12.7M | $525.1M | ||
| Q1 25 | $4.9M | $500.5M | ||
| Q4 24 | $1.6M | $594.4M | ||
| Q3 24 | $1.4M | $427.6M | ||
| Q2 24 | $5.3M | $474.3M | ||
| Q1 24 | $5.7M | $296.3M |
总债务GORORXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益GORORXRX
| Q4 25 | $44.0M | $1.1B | ||
| Q3 25 | $26.0M | $1.0B | ||
| Q2 25 | $19.2M | $919.1M | ||
| Q1 25 | $24.6M | $933.9M | ||
| Q4 24 | $27.3M | $1.0B | ||
| Q3 24 | $37.9M | $524.6M | ||
| Q2 24 | $49.8M | $584.4M | ||
| Q1 24 | $74.9M | $401.2M |
总资产GORORXRX
| Q4 25 | $184.1M | $1.5B | ||
| Q3 25 | $164.3M | $1.4B | ||
| Q2 25 | $155.1M | $1.3B | ||
| Q1 25 | $147.7M | $1.3B | ||
| Q4 24 | $145.9M | $1.4B | ||
| Q3 24 | $154.5M | $726.5M | ||
| Q2 24 | $161.5M | $775.9M | ||
| Q1 24 | $182.8M | $557.8M |
负债/权益比GORORXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $24.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $15.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 29.8% | -133.1% |
| 资本支出强度资本支出/营收 | 17.3% | 3.5% |
| 现金转化率经营现金流/净利润 | 1.34× | — |
| 过去12个月自由现金流最近4个季度 | $644.0K | $-378.3M |
8季度趋势，按日历期对齐
经营现金流GORORXRX
| Q4 25 | $24.2M | $-46.1M | ||
| Q3 25 | $-325.0K | $-117.4M | ||
| Q2 25 | $-1.3M | $-76.4M | ||
| Q1 25 | $-828.0K | $-132.0M | ||
| Q4 24 | $1.3M | $-115.4M | ||
| Q3 24 | $-3.4M | $-59.2M | ||
| Q2 24 | $-63.0K | $-82.2M | ||
| Q1 24 | $1.5M | $-102.3M |
自由现金流GORORXRX
| Q4 25 | $15.3M | $-47.3M | ||
| Q3 25 | $-7.8M | $-117.6M | ||
| Q2 25 | $-3.8M | $-79.6M | ||
| Q1 25 | $-3.0M | $-133.8M | ||
| Q4 24 | $58.0K | $-116.7M | ||
| Q3 24 | $-5.7M | $-63.8M | ||
| Q2 24 | $-2.1M | $-83.4M | ||
| Q1 24 | $-512.0K | $-109.0M |
自由现金流率GORORXRX
| Q4 25 | 29.8% | -133.1% | ||
| Q3 25 | -31.3% | -2272.5% | ||
| Q2 25 | -34.2% | -413.9% | ||
| Q1 25 | -24.4% | -907.4% | ||
| Q4 24 | 0.4% | -2567.7% | ||
| Q3 24 | -43.1% | -244.6% | ||
| Q2 24 | -10.0% | -578.5% | ||
| Q1 24 | -2.7% | -789.9% |
资本支出强度GORORXRX
| Q4 25 | 17.3% | 3.5% | ||
| Q3 25 | 30.0% | 4.7% | ||
| Q2 25 | 22.6% | 16.4% | ||
| Q1 25 | 17.7% | 12.4% | ||
| Q4 24 | 9.8% | 28.6% | ||
| Q3 24 | 17.7% | 17.5% | ||
| Q2 24 | 9.7% | 8.2% | ||
| Q1 24 | 10.7% | 48.2% |
现金转化率GORORXRX
| Q4 25 | 1.34× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
